Mark Vignola

Mark Vignola

Geen lopende functies
49 jaar
Consumer Services
Health Technology
Finance

Profiel

Mark J.
Vignola
formerly worked at Lehman Brothers, Inc., as Analyst in 2000, Intercept Pharmaceuticals, Inc., as Head-Corporate Development from 2018 to 2019, Needham & Co. LLC, as Equity Research Associate from 2011 to 2015, Duke University Medical Center, as Research Assistant in 2011, Applied Therapeutics, Inc., as Chief Financial Officer from 2019 to 2020, and Terns Pharmaceuticals, Inc., as Chief Financial Officer & Treasurer from 2021 to 2025.
Dr. Vignola received his graduate degree in 2002 from Duke University, undergraduate degree in 1999 from Boston College, and doctorate degree from Duke University School of Medicine.

Eerdere bekende functies van Mark Vignola

BedrijvenFunctieEinde
TERNS PHARMACEUTICALS, INC. Financieel Directeur/CFO 01-02-2025
APPLIED THERAPEUTICS, INC. Financieel Directeur/CFO 01-05-2020
INTERCEPT PHARMACEUTICALS, INC. Investor Relations Contact 01-05-2019
Analyst-Equity 01-05-2015
Corporate Officer/Principal 01-01-2011
Ervaring van Mark Vignola in detail bekijken

Opleiding van Mark Vignola

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

92

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Finance

Health Technology

Consumer Services

Finance

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Mark Vignola